Skip to main content

Table 5 Poor outcomes of acute ischemic stroke patients and hospital regions

From: Geographic differences in pharmacotherapy patterns and outcomes of acute ischemic stroke in China

Poor outcome

All

East

Northeast

Central

West

At 3 months a

1935 (20.7)

973 (22.3)

461 (19.2)

368 (18.5)

133 (22.9)

 Crude

 

Ref.

0.83 (0.73–0.94)**

0.79 (0.69–0.91)**

1.03 (0.84–1.27)

 Adjusted

 

Ref.

0.85 (0.74–0.98)*

0.69 (0.60–0.81)**

1.01 (0.80–1.27)

At 12 months a

1373 (15.8)

682 (16.9)

315 (14.3)

290 (15.3)

86 (15.9)

 Crude

 

Ref.

0.82 (0.71–0.94)**

0.89 (0.77–1.03)

0.93 (0.73–1.19)

 Adjusted

 

Ref.

0.84 (0.72–0.99)*

0.81 (0.69–0.96)*

0.89 (0.68–1.16)

  1. *P < 0.05, **P < 0.01, apercentage based on non-missing values
  2. Results are presented as n (%) and odds ratio (95% confidence interval)
  3. Adjusted for demographics (age, sex, medical insurance), medical history (hypertension, diabetes, dyslipidemia, atrial fibrillation, history of stroke including previous ischemic stroke and/or hemorrhagic stroke, coronary artery disease, and history of tumors), clinical features of the index stroke including National Institutes of Health Stroke Scale score and Glasgow Coma Scale score on admission, and hospital level